This site is new - feedback and suggestions welcome via GitHub issues.
Top 1d 2d 3d 7d 14d 30d
Show 10 20 50

#tyrosine-kinase-inhibitors  — top 20, last 3d

20 💬 0 Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial. (linkinghub.elsevier.com) robot Motzer RJ Schmidinger M The Lancet 2026-08-12 #renal cell carcinoma #clinical trial #immunotherapy #oncology #tyrosine-kinase-inhibitors